10.14
price down icon0.10%   -0.010
after-market Dopo l'orario di chiusura: 10.14
loading
Precedente Chiudi:
$10.15
Aprire:
$10
Volume 24 ore:
42,412
Relative Volume:
0.29
Capitalizzazione di mercato:
$246.27M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.20%
1M Prestazione:
-34.37%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$9.68
$10.49
Intervallo di 1 settimana:
Value
$9.68
$11.13
Portata 52W:
Value
$9.68
$17.31

Artiva Biotherapeutics Inc Stock (ARTV) Company Profile

Name
Nome
Artiva Biotherapeutics Inc
Name
Telefono
(858) 267-4467
Name
Indirizzo
5505 MOREHOUSE DRIVE, SAN DIEGO
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
ARTV's Discussions on Twitter

Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-13 Iniziato Cantor Fitzgerald Overweight
2024-08-13 Iniziato Jefferies Buy
2024-08-13 Iniziato Needham Buy
2024-08-13 Iniziato TD Cowen Buy
2024-08-13 Iniziato Wedbush Outperform

Artiva Biotherapeutics Inc Borsa (ARTV) Ultime notizie

pulisher
Oct 27, 2024

Cell therapy developer Artiva refiles for a $100M IPO - MSN

Oct 27, 2024
pulisher
Oct 23, 2024

Artiva Biotherapeutics appoints new board member By Investing.com - Investing.com Australia

Oct 23, 2024
pulisher
Oct 23, 2024

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors - ForexTV.com

Oct 23, 2024
pulisher
Oct 22, 2024

Artiva Biotherapeutics, Inc. Appoints Alison Moore as an Independent Member of Its Board of Directors - Marketscreener.com

Oct 22, 2024
pulisher
Oct 22, 2024

Artiva Biotherapeutics appoints new board member - Investing.com

Oct 22, 2024
pulisher
Oct 15, 2024

Artiva, Century, others extend natural-killer autoimmune push - BioWorld Online

Oct 15, 2024
pulisher
Oct 15, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Stock Price Down 5.4%Time to Sell? - MarketBeat

Oct 15, 2024
pulisher
Sep 28, 2024

Wall Street SWOT: Artiva Biotherapeutics stockNK cell pioneer targets autoimmune market By Investing.com - Investing.com South Africa

Sep 28, 2024
pulisher
Sep 23, 2024

The Attractiveness of Investing In Artiva Biotherapeutics Inc (ARTV) is Growing - Knox Daily

Sep 23, 2024
pulisher
Sep 21, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Trading 6.2% Higher - MarketBeat

Sep 21, 2024
pulisher
Sep 10, 2024

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference - GlobeNewswire

Sep 10, 2024
pulisher
Aug 29, 2024

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

Aug 29, 2024
pulisher
Aug 29, 2024

This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment - AOL

Aug 29, 2024
pulisher
Aug 21, 2024

Artiva Biotherapeutics, Inc.’s (NASDAQ:ARTV) Quiet Period Will End on August 28th - Defense World

Aug 21, 2024
pulisher
Aug 21, 2024

Artiva Biotherapeutics, Inc.'s Quiet Period Set To Expire on August 28th (NASDAQ:ARTV) - MarketBeat

Aug 21, 2024
pulisher
Aug 16, 2024

Brokers Issue Forecasts for Artiva Biotherapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:ARTV) - MarketBeat

Aug 16, 2024
pulisher
Aug 15, 2024

Analysts Set Expectations for Artiva Biotherapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:ARTV) - Defense World

Aug 15, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Stock Quotes, Forecast and News Summary - Benzinga

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch - Benzinga

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Receives New Coverage from Analysts at TD Cowen - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Needham & Company LLC Initiates Coverage on Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Wedbush Initiates Coverage on Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat

Aug 13, 2024
pulisher
Aug 13, 2024

Artiva Biotherapeutics (NASDAQ:ARTV) Coverage Initiated by Analysts at Cantor Fitzgerald - Defense World

Aug 13, 2024
pulisher
Aug 12, 2024

Non-Hodgkin Lymphoma Drugs Pipeline 2024 | Novartis, AstraZeneca, Genentech, BioInvent, Genmab, SystImmune, Nordic Nanovector, Pacylex Pharmaceuticals, Artiva Biotherapeutics, Inc - Barchart

Aug 12, 2024
pulisher
Aug 06, 2024

July IPOs to Watch in Tech, Biotech, Food Security and Transportation - Investorideas.com newswire

Aug 06, 2024
pulisher
Jul 28, 2024

Insider Buying in These 2 IPOs Is Huge, Plus Financial CEOs Pick Up Shares - 24/7 Wall St.

Jul 28, 2024
pulisher
Jul 28, 2024

Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal - Seeking Alpha

Jul 28, 2024
pulisher
Jul 23, 2024

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Director Yong-Jun Huh Buys 2,083,332 Shares - Defense World

Jul 23, 2024
pulisher
Jul 23, 2024

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Major Shareholder Global Strategic Fund I. Venbio Purchases 416,666 Shares - Defense World

Jul 23, 2024
pulisher
Jul 23, 2024

VenBio fund acquires $5m in Artiva Biotherapeutics stock By Investing.com - Investing.com Australia

Jul 23, 2024
pulisher
Jul 22, 2024

VenBio fund acquires $5m in Artiva Biotherapeutics stock - Investing.com India

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva Biotherapeutics sees major stock purchases by GC Corp entities - Investing.com South Africa

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva Biotherapeutics director Yong-Jun Huh buys $25m in IPO By Investing.com - Investing.com South Africa

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva Biotherapeutics director Yong-Jun Huh buys $25m in IPO - Investing.com India

Jul 22, 2024
pulisher
Jul 22, 2024

Artiva: Natural Killer Cell Biotech With First Half Of 2025 Lupus Treatment Data - Seeking Alpha

Jul 22, 2024
pulisher
Jul 21, 2024

Artiva’s IPO Reels In $167M to Bring NK Cell Therapy to Autoimmune Diseases - MedCity News

Jul 21, 2024
pulisher
Jul 20, 2024

Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Jul 20, 2024
pulisher
Jul 20, 2024

Artiva Biotherapeutics surges on trading debut - MSN

Jul 20, 2024
pulisher
Jul 19, 2024

Public Equity Report: Artiva’s debut comes amid underwhelming IPO season - BioCentury

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva Biotherapeutics IPO opens at $16, priced at $12 By Investing.com - Investing.com Canada

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva prices $167M IPO as its AlloNK cell therapy advances - BioWorld Online

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva Shares Jump 30% After Upsized $167 Million US IPO - Bloomberg

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva Biotherapeutics announces pricing of upsized $167M IPO - MSN

Jul 19, 2024
pulisher
Jul 19, 2024

Cooley, Latham Lead Biotech Firm Artiva's Upsized $167M IPO - Law360

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva Biotherapeutics stock in trading debut (Pending:ARTV) - Seeking Alpha

Jul 19, 2024
pulisher
Jul 19, 2024

Watkins Advises on Artiva Biotherapeutics’ US$167.0 Million Initial Public Offering - Latham & Watkins LLP -

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva Biotherapeutics Prices 13.92M Share IPO at $12/sh - Investing.com

Jul 19, 2024
pulisher
Jul 19, 2024

Artiva Biotherapeutics announces pricing of upsized $167M IPO (Pending:ARTV) - Seeking Alpha

Jul 19, 2024

Artiva Biotherapeutics Inc Azioni (ARTV) Dati Finanziari

Non sono disponibili dati finanziari per Artiva Biotherapeutics Inc (ARTV). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.32
price down icon 1.11%
$74.12
price up icon 0.26%
$373.97
price up icon 3.48%
$54.36
price down icon 0.66%
$202.64
price down icon 1.63%
$113.10
price down icon 0.74%
Capitalizzazione:     |  Volume (24 ore):